Petros Pharmaceuticals Inc (PTPI)
0.6344
-0.05
(-6.72%)
USD |
NASDAQ |
Apr 24, 16:00
0.6308
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Profit Margin (Quarterly): -87.34% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -87.34% |
| September 30, 2023 | -271.7% |
| June 30, 2023 | -127.7% |
| March 31, 2023 | -55.01% |
| December 31, 2022 | -528.9% |
| September 30, 2022 | |
| June 30, 2022 | -43.28% |
| March 31, 2022 | -7.07% |
| Date | Value |
|---|---|
| December 31, 2021 | |
| September 30, 2021 | -79.10% |
| June 30, 2021 | -85.97% |
| March 31, 2021 | 73.83% |
| December 31, 2020 | -185.6% |
| September 30, 2020 | -95.26% |
| June 30, 2020 | -419.7% |
| March 31, 2020 | -339.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-528.9%
Minimum
Dec 2022
73.83%
Maximum
Mar 2021
-160.9%
Average
-91.30%
Median
Profit Margin (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -1.43K% |
| Spectral AI Inc | -309.0% |
| Imunon Inc | -- |
| Assembly Biosciences Inc | -153.0% |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.15% |
| Return on Assets | -24.82% |
| Return on Invested Capital | -37.66% |
| Return on Net Operating Assets | -29.72% |